Skip to main content

Dogwood Therapeutics, Inc.

corporate_fare Company Profile

Dogwood Therapeutics, Inc.

DWTX·NASDAQ·Life Sciences·CIK 0001818844

Our Company is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. Following a combination, the company became the sole owner of Pharmagesic (Holdings) Inc. and its wholly owned subsidiary, Wex Pharmaceuticals, Inc. Wex Pharmaceuticals, Inc. wholly owns IWT Bio, Inc., Wex Medical Corporation, and Wex Medical Limited. The company's pipeline is focused on treating chronic neuropathic pain and neuropathy. Its Halneuron® Na v 1.7 modulation program is intended to treat chronic and acute pain disorders. The recently licensed SP16 program is centered on a cell signaling molecule that has shown early promise in treating neuropathy and nerve damage. The Halneuron® program is a proprietary non-opioid Na v 1.7 analgesic program centered on voltage-gated sodium channel modulation. SP16 is the focus of a planned Phase 1b study that is fully funded through a research grant supplied by the National Cancer Institute, with patient enrollment projected to start in mid-2026. The lead product candidate, Halneuron®, is in late-stage clinical development for the treatment of chemotherapy-induced neuropathic pain ("CINP"). The active pharmaceutical ingredient is highly purified Tetrodotoxin ("TTX"), a potent sodium channel modulator. Halneuron® works as an analgesic by modulating the activity of Na v 1.7, a key sodium channel involved in pain signal transmission.

Dogwood Therapeutics, Inc. (NASDAQ:DWTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 25 items for DWTX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for DWTX spans 10-Q, 8-K, DEF 14A, PRE 14A.

Recent high-impact activity:

  • Dogwood Q3 Loss Narrows to $4.9M; Going Concern Doubt Persists With Cash Through March 2027
  • Dogwood Narrows Q3 Loss to $4.9M as Halneuron Phase 2b Readout Lands This Month
  • Dogwood Raises $5M From 64% Holder Sealbond at $1.22/Share
  • Dogwood Raises $5M in Private Placement With CK Life Sciences
  • Dogwood Completes Enrollment in Halneuron Phase 2b Trial, Topline Data Due November

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$34.26M
Diluted EPS
-$7.13
Op. Cash Flow
-$15.62M
Operating Income
-$27.97M
Cash & Equivalents
$6.52M
Debt / Equity
0.00×
Shares Outstanding
29.74M sh
Source: 10-K · filed 2026-03-18 · accession 0001104659-26-031061

Short Interest & Short Volume

1.65 days to cover

FINRA reported short interest of 111,693 shares in DWTX as of the October 30, 2026 settlement, a 79.0% increase from the prior period — about 1.6 days to cover at its recent average daily volume. On November 20, 2026, 40.9% of DWTX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)111,693 shares as of October 30, 2026
Change vs prior period▲ 79.0%
Days to cover1.65 at avg daily volume of 67,836
Daily short volume (FINRA facilities)40.9% of 72,282 shares on November 20, 2026
5-day average short volume38.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for DWTX, detected from its recent SEC filings.

1 shelf registration

Resale Registration for Sealbond Shares · No New Capital or Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with D →
$1.29 +24.64% today
52-week range · as of 2026-11-06 $0.901 – $7.04
Market cap
$39.57M
Volume
645.8K (5.2× avg)
3-mo avg 124.3K
Live data · 2026-11-21 12:12 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed DWTX - Latest Insights

DWTX
Nov 06, 2026, 9:18 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.10
Real-time Price: $1.29 info
Change: +$0.190 (+17%) info
Market Cap: $39.566M info
DWTX
Nov 05, 2026, 8:30 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.10
Real-time Price: $1.29 info
Change: +$0.190 (+17%) info
Market Cap: $39.566M info
DWTX
Oct 19, 2026, 8:45 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.36
Real-time Price: $1.29 info
Change: -$0.070 (-5%) info
Market Cap: $39.566M info
DWTX
Oct 19, 2026, 8:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.25
Real-time Price: $1.29 info
Change: +$0.040 (+3%) info
Market Cap: $39.566M info
DWTX
Sep 14, 2026, 8:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.04
Real-time Price: $1.29 info
Change: -$0.750 (-37%) info
Market Cap: $39.566M info
DWTX
Aug 14, 2026, 11:14 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.99
Real-time Price: $1.29 info
Change: -$0.700 (-35%) info
Market Cap: $39.566M info
DWTX
Aug 13, 2026, 8:50 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.80
Real-time Price: $1.29 info
Change: -$0.510 (-28%) info
Market Cap: $39.566M info
DWTX
Aug 13, 2026, 8:39 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.80
Real-time Price: $1.29 info
Change: -$0.510 (-28%) info
Market Cap: $39.566M info
DWTX
Jun 17, 2026, 4:55 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.55
Real-time Price: $1.29 info
Change: -$0.260 (-17%) info
Market Cap: $39.566M info
DWTX
May 15, 2026, 9:20 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.97
Real-time Price: $1.29 info
Change: -$0.680 (-35%) info
Market Cap: $39.566M info
DWTX
May 14, 2026, 8:50 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.85
Real-time Price: $1.29 info
Change: -$0.560 (-30%) info
Market Cap: $39.566M info
DWTX
May 14, 2026, 8:38 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $1.85
Real-time Price: $1.29 info
Change: -$0.560 (-30%) info
Market Cap: $39.566M info
DWTX
Apr 27, 2026, 2:30 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $1.43
Real-time Price: $1.29 info
Change: -$0.140 (-10%) info
Market Cap: $39.566M info
DWTX
Apr 17, 2026, 5:26 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $1.66
Real-time Price: $1.29 info
Change: -$0.370 (-22%) info
Market Cap: $39.566M info
DWTX
Apr 15, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.70
Real-time Price: $1.29 info
Change: -$0.410 (-24%) info
Market Cap: $39.566M info
DWTX
Mar 26, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.32
Real-time Price: $1.29 info
Change: -$1.03 (-44%) info
Market Cap: $39.566M info
DWTX
Mar 18, 2026, 4:30 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $2.97
Real-time Price: $1.29 info
Change: -$1.68 (-57%) info
Market Cap: $39.566M info
DWTX
Mar 18, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.11
Real-time Price: $1.29 info
Change: -$1.82 (-59%) info
Market Cap: $39.566M info
DWTX
Mar 18, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.11
Real-time Price: $1.29 info
Change: -$1.82 (-59%) info
Market Cap: $39.566M info
DWTX
Mar 12, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.01
Real-time Price: $1.29 info
Change: -$1.72 (-57%) info
Market Cap: $39.566M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets